An Open Label, Phase III Clinical Trial (Immunobridging Study) of INAVAC (Vaksin Merah Putih - UA-SARS-CoV-2 (Vero Cell Inactivated)) in Healthy Population Aged 12 to 17 Years Old
Tahapan Penelitian : Complete
Sponsor:
BKPK Kemenkes
Mitra Pelaksana:
PT Biotis Pharmaceutical Indonesia, Universitas Airlangga
No Registry
INA-Q9EC6OB
Tanggal Input Registry : 19-07-2024
Tracking Information | |
---|---|
Tanggal Antisipasi Studi | 01-01-2023 |
Outcome Primer | not specified |
Outcome Skunder | |
Descriptive Information | |
Judul Penelitian Popular | An Open Label, Phase III Clinical Trial (Immunobridging Study) of INAVAC (Vaksin Merah Putih - UA-SARS-CoV-2 (Vero Cell Inactivated)) in Healthy Population Aged 12 to 17 Years Old |
Judul Penelitian Ilmiah | An Open Label, Phase III Clinical Trial (Immunobridging Study) of INAVAC (Vaksin Merah Putih - UA-SARS-CoV-2 (Vero Cell Inactivated)) in Healthy Population Aged 12 to 17 Years Old |
Jenis Penelitian | Interventional |
Intervensi | INAVAC (Vaksin Merah Putih - UA-SARS-CoV-2 (Vero Cell Inactivated)) |
Jumlah Subyek Penelitian | 5 |
Recruitment Information | |
Eligibility Criteria | Inclusion Criteria: not specifiedExclusion Criteria: not specified |
Administrative Information | |
Nomor Persetujuan Etik | not specified |
Nomor Persetujuan Material Transfer Agreement | Not applicable |
Nomor Persetujuan Pelaksanaan Uji Klinik | PPUK/PPUB number |
Other Study ID Numbers | |
Contact Person | not specified |